Shepherd Kaplan Krochuk’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-4,094
| Closed | -$318K | – | 256 |
|
|
2017
Q4 | $318K | Sell |
4,094
-4,075
| -50% | -$317K | 0.2% | 131 |
|
|
2017
Q3 | $501K | Hold |
8,169
| – | – | 0.42% | 71 |
|
|
2017
Q2 | $376K | Hold |
8,169
| – | – | 0.22% | 99 |
|
|
2017
Q1 | $354K | Buy |
8,169
+2,880
| +54% | +$125K | 0.18% | 109 |
|
|
2016
Q4 | $205K | Sell |
5,289
-4,054
| -43% | -$157K | 0.06% | 165 |
|
|
2016
Q3 | $473K | Hold |
9,343
| – | – | 0.1% | 138 |
|
|
2016
Q2 | $425K | Hold |
9,343
| – | – | 0.11% | 125 |
|
|
2016
Q1 | $370K | Sell |
9,343
-3,114
| -25% | -$123K | 0.11% | 122 |
|
|
2015
Q4 | $705K | Sell |
12,457
-17,211
| -58% | -$974K | 0.19% | 74 |
|
|
2015
Q3 | $1.18M | Sell |
29,668
-5,770
| -16% | -$229K | 0.31% | 48 |
|
|
2015
Q2 | $1.69M | Hold |
35,438
| – | – | 0.32% | 48 |
|
|
2015
Q1 | $1.41M | Sell |
35,438
-25,260
| -42% | -$1M | 0.25% | 67 |
|
|
2014
Q4 | $1.36M | Hold |
60,698
| – | – | 0.22% | 91 |
|
|
2014
Q3 | $951K | Buy |
60,698
+6,910
| +13% | +$108K | 0.12% | 135 |
|
|
2014
Q2 | $798K | Buy |
53,788
+26,117
| +94% | +$387K | 0.08% | 157 |
|
|
2014
Q1 | $446K | Hold |
27,671
| – | – | 0.05% | 216 |
|
|
2013
Q4 | $258K | Hold |
27,671
| – | – | 0.03% | 372 |
|
|
2013
Q3 | $313K | Hold |
27,671
| – | – | 0.05% | 261 |
|
|
2013
Q2 | $370K | Buy |
+27,671
| New | +$370K | 0.07% | 232 |
|